At a time when the global healthcare landscape is constantly changing and demand for reliable medicines continues to rise, the latest Austrian Health Report has revealed a remarkable trend among the Austrian population. An overwhelming majority of 81 per cent consider the manufacture of medicinal products in their own country to be (very) important. This strong commitment to domestic pharmaceutical production not only underlines the importance of local production for the Austrian economy and security of supply, but also sends a clear signal to policymakers to improve the framework conditions for the pharmaceutical industry in Austria.
Alexander Herzog, Secretary General of PHARMIG, emphasises the importance of this development and sees it as an opportunity not only to maintain existing capacities but ideally to expand them. The benefits are obvious: stronger domestic production can boost the economy and increase security of supply, which is invaluable in the current global situation.
Interestingly, the report also shows that the population would be willing to pay more for medicines manufactured in Austria. This points to a growing awareness that quality and safety come at a price and that a pure low-price policy could jeopardise supply in the long term. On average, around 20 medicinal products drop out of the Austrian reimbursement code (Erstattungskodex) every month, which underlines the urgency of fair prices and long-term planning certainty.
Herzog points out that fair prices and planning certainty are essential to stabilise the pharmaceutical industry in Austria. Only in this way can companies maintain or even expand their sites and thus contribute to the diversity of available medicinal products. This not only strengthens the quality of care in Austria but also makes the country an internationally sought-after production location.
The results and further information on the Austrian Health Report are available at www.austrianhealthreport.at. This initiative highlights the need to strengthen domestic pharmaceutical production and provides a basis for future discussions and measures in this area.
Peter Richter, Head of Communications & PR at PHARMIG, is available for enquiries. His contact details and further information can be found on the PHARMIG website.
In a world where the safety and quality of medicines are of the utmost importance, the Austrian Health Report clearly shows that the Austrian population supports a strong local pharmaceutical industry. Now is the time to listen to these voices and to work together towards a future in which Austria is known not only for its picturesque landscapes but also as a centre of high-quality pharmaceutical production.
Source (in German): https://www.pharmig.at/mediathek/pressecorner/arzneimittelproduktion-in-oesterreich-staerken/
